Your browser doesn't support javascript.
loading
Persistence Rate with Tadalafil for Treatment of Male Lower Urinary Tract Symptoms.
Wada, Naoki; Kikuchi, Daiki; Tateoka, Jo; Abe, Noriyuki; Watanabe, Masaki; Tamaki, Gaku; Kita, Masafumi; Kakizaki, Hidehiro.
Affiliation
  • Wada N; Department of Renal and Urologic Surgery, Asahikawa Medical University, Asahikawa, Japan, nwada@asahikawa-med.ac.jp.
  • Kikuchi D; Department of Renal and Urologic Surgery, Asahikawa Medical University, Asahikawa, Japan.
  • Tateoka J; Department of Renal and Urologic Surgery, Asahikawa Medical University, Asahikawa, Japan.
  • Abe N; Department of Renal and Urologic Surgery, Asahikawa Medical University, Asahikawa, Japan.
  • Watanabe M; Department of Renal and Urologic Surgery, Asahikawa Medical University, Asahikawa, Japan.
  • Tamaki G; Department of Renal and Urologic Surgery, Asahikawa Medical University, Asahikawa, Japan.
  • Kita M; Department of Renal and Urologic Surgery, Asahikawa Medical University, Asahikawa, Japan.
  • Kakizaki H; Department of Renal and Urologic Surgery, Asahikawa Medical University, Asahikawa, Japan.
Urol Int ; 104(5-6): 373-377, 2020.
Article in En | MEDLINE | ID: mdl-32348992

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phosphodiesterase 5 Inhibitors / Lower Urinary Tract Symptoms / Tadalafil Type of study: Diagnostic_studies / Observational_studies Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Urol Int Year: 2020 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phosphodiesterase 5 Inhibitors / Lower Urinary Tract Symptoms / Tadalafil Type of study: Diagnostic_studies / Observational_studies Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Urol Int Year: 2020 Document type: Article Country of publication: